vs
Side-by-side financial comparison of ThredUp Inc. (TDUP) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
ThredUp Inc. is the larger business by last-quarter revenue ($79.7M vs $70.6M, roughly 1.1× Viridian Therapeutics, Inc.\DE). ThredUp Inc. runs the higher net margin — -7.0% vs -49.0%, a 42.0% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 18.5%). ThredUp Inc. produced more free cash flow last quarter ($-3.2M vs $-84.7M).
ThredUp Inc. is an American company that operates an online resale platform specializing in the sale of second-hand clothing, footwear, and accessories. Founded in 2009 and headquartered in Oakland, California, it has established itself as one of the leading resale fashion marketplaces.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
TDUP vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $79.7M | $70.6M |
| Net Profit | $-5.6M | $-34.6M |
| Gross Margin | 79.6% | — |
| Operating Margin | -8.4% | -56.7% |
| Net Margin | -7.0% | -49.0% |
| Revenue YoY | 18.5% | 81958.1% |
| Net Profit YoY | 74.3% | 54.9% |
| EPS (diluted) | $-0.06 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.7M | — | ||
| Q3 25 | $82.2M | $70.6M | ||
| Q2 25 | $77.7M | — | ||
| Q1 25 | $71.3M | — | ||
| Q4 24 | $67.3M | — | ||
| Q3 24 | $61.5M | — | ||
| Q2 24 | $66.7M | — | ||
| Q1 24 | $64.5M | — |
| Q4 25 | $-5.6M | — | ||
| Q3 25 | $-4.2M | $-34.6M | ||
| Q2 25 | $-5.2M | — | ||
| Q1 25 | $-5.2M | — | ||
| Q4 24 | $-21.7M | — | ||
| Q3 24 | $-24.8M | — | ||
| Q2 24 | $-14.0M | — | ||
| Q1 24 | $-16.6M | — |
| Q4 25 | 79.6% | — | ||
| Q3 25 | 79.4% | — | ||
| Q2 25 | 79.5% | — | ||
| Q1 25 | 79.1% | — | ||
| Q4 24 | 80.4% | — | ||
| Q3 24 | 79.3% | — | ||
| Q2 24 | 78.8% | — | ||
| Q1 24 | 80.1% | — |
| Q4 25 | -8.4% | — | ||
| Q3 25 | -5.3% | -56.7% | ||
| Q2 25 | -6.8% | — | ||
| Q1 25 | -7.6% | — | ||
| Q4 24 | -12.1% | — | ||
| Q3 24 | -17.0% | — | ||
| Q2 24 | -14.4% | — | ||
| Q1 24 | -19.2% | — |
| Q4 25 | -7.0% | — | ||
| Q3 25 | -5.2% | -49.0% | ||
| Q2 25 | -6.7% | — | ||
| Q1 25 | -7.3% | — | ||
| Q4 24 | -32.3% | — | ||
| Q3 24 | -40.3% | — | ||
| Q2 24 | -20.9% | — | ||
| Q1 24 | -25.7% | — |
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-0.04 | — | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $-0.19 | — | ||
| Q3 24 | $-0.22 | — | ||
| Q2 24 | $-0.13 | — | ||
| Q1 24 | $-0.15 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $38.6M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $59.2M | $503.0M |
| Total Assets | $167.2M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.6M | — | ||
| Q3 25 | $46.2M | $490.9M | ||
| Q2 25 | $41.0M | — | ||
| Q1 25 | $41.1M | — | ||
| Q4 24 | $31.9M | — | ||
| Q3 24 | $43.7M | — | ||
| Q2 24 | $44.8M | — | ||
| Q1 24 | $50.1M | — |
| Q4 25 | $59.2M | — | ||
| Q3 25 | $59.1M | $503.0M | ||
| Q2 25 | $60.2M | — | ||
| Q1 25 | $56.1M | — | ||
| Q4 24 | $56.3M | — | ||
| Q3 24 | $69.3M | — | ||
| Q2 24 | $86.5M | — | ||
| Q1 24 | $93.5M | — |
| Q4 25 | $167.2M | — | ||
| Q3 25 | $172.5M | $577.1M | ||
| Q2 25 | $173.6M | — | ||
| Q1 25 | $172.5M | — | ||
| Q4 24 | $171.2M | — | ||
| Q3 24 | $214.9M | — | ||
| Q2 24 | $231.2M | — | ||
| Q1 24 | $244.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.5M | $-84.6M |
| Free Cash FlowOCF − Capex | $-3.2M | $-84.7M |
| FCF MarginFCF / Revenue | -4.0% | -120.1% |
| Capex IntensityCapex / Revenue | 2.2% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $180.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.5M | — | ||
| Q3 25 | $6.0M | $-84.6M | ||
| Q2 25 | $344.0K | — | ||
| Q1 25 | $5.7M | — | ||
| Q4 24 | $663.0K | — | ||
| Q3 24 | $3.3M | — | ||
| Q2 24 | $-5.0M | — | ||
| Q1 24 | $1.4M | — |
| Q4 25 | $-3.2M | — | ||
| Q3 25 | $2.4M | $-84.7M | ||
| Q2 25 | $-2.9M | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $-1.8M | — | ||
| Q3 24 | $1.2M | — | ||
| Q2 24 | $-5.8M | — | ||
| Q1 24 | $267.0K | — |
| Q4 25 | -4.0% | — | ||
| Q3 25 | 2.9% | -120.1% | ||
| Q2 25 | -3.8% | — | ||
| Q1 25 | 5.5% | — | ||
| Q4 24 | -2.7% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | -8.7% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 2.2% | — | ||
| Q3 25 | 4.4% | 0.2% | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | 3.5% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 1.7% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
